small molecule

VANIQA

EFLORNITHINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity

CompanyAbbVie Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand name	VANIQA
Active ingredient	EFLORNITHINE HYDROCHLORIDE
Strength	13.9%
Dosage form	CREAM
Route	TOPICAL
Modality	Small molecule
FDA approval	July 2000
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.